These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6423543)

  • 21. The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs.
    Brandt L; Skeiky YA; Alderson MR; Lobet Y; Dalemans W; Turner OC; Basaraba RJ; Izzo AA; Lasco TM; Chapman PL; Reed SG; Orme IM
    Infect Immun; 2004 Nov; 72(11):6622-32. PubMed ID: 15501795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of allergy in children in relation to prior BCG vaccination and infection with atypical mycobacteria.
    Strannegård IL; Larsson LO; Wennergren G; Strannegård O
    Allergy; 1998 Mar; 53(3):249-54. PubMed ID: 9542604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterologous Boost Following
    Wu Y; Cai M; Ma J; Teng X; Tian M; Bassuoney EBMB; Fan X
    Front Immunol; 2018; 9():2439. PubMed ID: 30425711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system.
    Majlessi L; Brodin P; Brosch R; Rojas MJ; Khun H; Huerre M; Cole ST; Leclerc C
    J Immunol; 2005 Mar; 174(6):3570-9. PubMed ID: 15749894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study on detection of the Mycobacteria DNA in formalin-fixed, paraffin-embedded tissue samples by triplex polymerase chain reaction].
    Li Z; Qin W; Yue Q; Meng K; Lin Q
    Wei Sheng Wu Xue Bao; 2002 Feb; 42(1):69-75. PubMed ID: 12557351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of atypical mycobacterial infection on the cell-mediated immunity induced by Mycobacterium bovis BCG in mice. II. Suppression of protective immunity].
    Nakamura RM
    Kekkaku; 1993 May; 68(5):361-5. PubMed ID: 8331880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mice fed lipid-encapsulated Mycobacterium bovis BCG are protected against aerosol challenge with Mycobacterium tuberculosis.
    Aldwell FE; Brandt L; Fitzpatrick C; Orme IM
    Infect Immun; 2005 Mar; 73(3):1903-5. PubMed ID: 15731098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice.
    Aldwell FE; Tucker IG; de Lisle GW; Buddle BM
    Infect Immun; 2003 Jan; 71(1):101-8. PubMed ID: 12496154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis.
    Buddle BM; Wards BJ; Aldwell FE; Collins DM; de Lisle GW
    Vaccine; 2002 Jan; 20(7-8):1126-33. PubMed ID: 11803073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis.
    Zelmer A; Tanner R; Stylianou E; Damelang T; Morris S; Izzo A; Williams A; Sharpe S; Pepponi I; Walker B; Hokey DA; McShane H; Brennan M; Fletcher H
    BMC Infect Dis; 2016 Aug; 16():412. PubMed ID: 27519524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of atypical mycobacterial infection on the cell-mediated immunity induced by Mycobacterium bovis BCG in mice. I. Suppression of delayed-type hypersensitivity].
    Nakamura RM; Goto Y; Kinomoto M
    Kekkaku; 1990 Sep; 65(9):581-4. PubMed ID: 2232436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection by novel vaccine candidates, Mycobacterium tuberculosis ΔmosR and ΔechA7, against challenge with a Mycobacterium tuberculosis Beijing strain.
    Marcus SA; Steinberg H; Talaat AM
    Vaccine; 2015 Oct; 33(42):5633-5639. PubMed ID: 26363381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization with a DNA vaccine cocktail protects mice lacking CD4 cells against an aerogenic infection with Mycobacterium tuberculosis.
    Derrick SC; Repique C; Snoy P; Yang AL; Morris S
    Infect Immun; 2004 Mar; 72(3):1685-92. PubMed ID: 14977976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for the Effect of Vaccination on Host-Pathogen Interactions in a Murine Model of Pulmonary Tuberculosis by
    Zatarain-Barrón ZL; Ramos-Espinosa O; Marquina-Castillo B; Barrios-Payán J; Cornejo-Granados F; Maya-Lucas O; López-Leal G; Molina-Romero C; Anthony RM; Ochoa-Leyva A; De La Rosa-Velázquez IA; Rebollar-Vega RG; Warren RM; Mata-Espinosa DA; Hernández-Pando R; van Soolingen D
    Front Immunol; 2020; 11():930. PubMed ID: 32508826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycobacterium bovis BCG vaccination augments interleukin-8 mRNA expression and protein production in guinea pig alveolar macrophages infected with Mycobacterium tuberculosis.
    Lyons MJ; Yoshimura T; McMurray DN
    Infect Immun; 2002 Oct; 70(10):5471-8. PubMed ID: 12228272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity and protection conferred by Mycobacterium habana in a murine model of pulmonary tuberculosis.
    Valdés I; Montoro E; Mata-Espinoza D; Asín O; Barrios-Payan J; Francisco-Cruz A; Valdivia JA; Hernández-Pando R
    Tuberculosis (Edinb); 2014 Jan; 94(1):65-72. PubMed ID: 24332882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterizing the BCG Induced Macrophage and Neutrophil Mechanisms for Defense Against
    Bickett TE; McLean J; Creissen E; Izzo L; Hagan C; Izzo AJ; Silva Angulo F; Izzo AA
    Front Immunol; 2020; 11():1202. PubMed ID: 32625209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
    Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ
    PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
    Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.